DAVA:NYSEEndava plc Analysis

Endava (DAVA) is trading at roughly $2.90, barely above its computed support of $2.67 and well below its 20‑day and 50‑day SMAs, signalling a bearish price environment. The 14‑day RSI sits in the mid‑30s, hinting at oversold conditions but not yet an outright reversal signal. Both the MACD line and its histogram are negative, reinforcing the downside momentum. Volume has been trending lower, and the 30‑day volatility exceeds 75%, underscoring a choppy, high‑risk trading range. Recent earnings released for Q3 2026 missed both revenue and EPS expectations, delivering a 74% earnings surprise and a 3.6% revenue shortfall. Leading analysts from Guggenheim and JP Morgan have cut their outlooks, moving from Buy/Neutral to Neutral/Underweight, which adds to the near‑term bearish sentiment.
Despite the setbacks, the company’s forward PE of just 3.4 versus an industry average of 36.8, a price‑to‑book under 1, and a DCF‑derived fair value near $4.15 suggest the stock is materially undervalued. Management is emphasizing AI‑driven transformation and new strategic partnerships, which could unlock higher‑margin digital engineering work. Free cash flow remains positive at roughly $31 million, providing a modest cushion for debt reduction. However, the balance sheet is leveraged, with a debt‑to‑equity ratio above 130% and a historic max drawdown of over 80%, keeping downside risk elevated. The blend of cheap valuation multiples and long‑term growth themes makes DAVA a candidate for a turnaround play, especially if the AI initiatives gain traction. Investors should therefore weigh the attractive upside against the pronounced volatility and leverage before committing capital.